- €1.52bn
- €1.61bn
- €359.89m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 337 | 388 | 446 | 455 | 360 |
Cost of Revenue | |||||
Gross Profit | 231 | 269 | 319 | 333 | 278 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 304 | 351 | 399 | 431 | 347 |
Operating Profit | 33 | 36.2 | 47.7 | 24.7 | 13.3 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 31.4 | 33.4 | 44.3 | 21.6 | 12 |
Provision for Income Taxes | |||||
Net Income After Taxes | 24.4 | 27.9 | 30.6 | 18.7 | 20.5 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 24.4 | 27.3 | 30.2 | 18.7 | 20.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 24.4 | 27.3 | 30.2 | 18.7 | 20.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.9 | 4.33 | 4.79 | 2.96 | 3.02 |
Dividends per Share |